These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10086445)

  • 1. Study of the Food and Drug Administration files on Propecia: dosages, side effects, and recommendations.
    Frankel S
    Arch Dermatol; 1999 Mar; 135(3):257-8. PubMed ID: 10086445
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
    Suchonwanit P; Iamsumang W; Rojhirunsakool S
    Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
    Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological and clinical profile of finasteride (PROPECIA)].
    Fukuzumi H; Ikeda T; Narita H; Takubo T; Matsuda T; Taniguchi T
    Nihon Yakurigaku Zasshi; 2006 Jun; 127(6):495-502. PubMed ID: 16880702
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.
    Ryu HK; Kim KM; Yoo EA; Sim WY; Chung BC
    Br J Dermatol; 2006 Apr; 154(4):730-4. PubMed ID: 16536818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
    Kaufman KD; Olsen EA; Whiting D; Savin R; DeVillez R; Bergfeld W; Price VH; Van Neste D; Roberts JL; Hordinsky M; Shapiro J; Binkowitz B; Gormley GJ
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):578-89. PubMed ID: 9777765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines on the use of finasteride in androgenetic alopecia.
    Mysore V; Shashikumar BM
    Indian J Dermatol Venereol Leprol; 2016; 82(2):128-34. PubMed ID: 26924401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gone today, hair tomorrow?
    Newsweek; 1997 Nov; 130(21):61. PubMed ID: 10174397
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
    Dallob AL; Sadick NS; Unger W; Lipert S; Geissler LA; Gregoire SL; Nguyen HH; Moore EC; Tanaka WK
    J Clin Endocrinol Metab; 1994 Sep; 79(3):703-6. PubMed ID: 8077349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finasteride revisited: Proscar for the prostate and Propecia for the pate.
    Harv Mens Health Watch; 2000 Jul; 4(12):1-4. PubMed ID: 10877872
    [No Abstract]   [Full Text] [Related]  

  • 12. Propecia: the goose that lays the golden eggs.
    Wolf R; Parish JL; Parish LC
    Skinmed; 2005; 4(2):67-8. PubMed ID: 15785131
    [No Abstract]   [Full Text] [Related]  

  • 13. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
    Spinucci G; Pasquali R
    Clin Ter; 1996 Jun; 147(6):305-15. PubMed ID: 8925640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propecia and Rogaine Extra Strength for alopecia.
    Med Lett Drugs Ther; 1998 Feb; 40(1021):25-7. PubMed ID: 9505960
    [No Abstract]   [Full Text] [Related]  

  • 15. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    Olsen EA; Hordinsky M; Whiting D; Stough D; Hobbs S; Ellis ML; Wilson T; Rittmaster RS;
    J Am Acad Dermatol; 2006 Dec; 55(6):1014-23. PubMed ID: 17110217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finasteride treatment of hair loss in women.
    Stout SM; Stumpf JL
    Ann Pharmacother; 2010 Jun; 44(6):1090-7. PubMed ID: 20442354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
    D'Amico AV; Roehrborn CG
    Lancet Oncol; 2007 Jan; 8(1):21-5. PubMed ID: 17196507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5 alpha-reductase and finasteride in pattern alopecia and acne.
    Burkhart CG; Burkhart CN
    J Drugs Dermatol; 2004; 3(4):363-4. PubMed ID: 15303779
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing].
    Wolff H; Kunte C
    MMW Fortschr Med; 1999 Sep; 141(37):38-40. PubMed ID: 10897972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finasteride: a review of its use in male pattern hair loss.
    McClellan KJ; Markham A
    Drugs; 1999 Jan; 57(1):111-26. PubMed ID: 9951956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.